1Needleman P, Johnson EMJ, Mechanism of tolerance development to organic nitrates. J Pharmacol EXP Ther, 1973, 184:709
2Dupis J, Lalomde G, Lemieux R, et al. Tolerance to intravenous nitroglycerin in patients with congestive heat failure:role of increased intravascular volume neurohumral activation and lack of prevention with N-acety lcysteine. J Am Cool Cardiol, 1990, 16:922
3Watanabe H, kakihana M, Ohtsuka S, et al. Double-blind,Placeba-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heat failure. Circulation, 1998, 97(9):886
3Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease[J].N Engl J Med,1997,337(6):408-416.
4Frei B. Reactive oxygen species and antioxidam vitamins:mechanisms of action[J].Am J Med,1994,97(3A):5S-13S.
5Needleman P, Johnson EMJ. Mechanism of tolerance development to organic nitrates.J Pharmacol EXP Ther, 1973,184:709.
6Watanabe H, kakihana M,Ohtsuka S,et al. Double-blind,Placeba- controlled study of ascorbate on the preventive effect of nitrate to lerance in patients with congestive heat failure. Girculation, 1998,97 (9) : 886.
7Chan AC.Vitamin E and atherosclerosis[J].J Nutr, 1998,128 (10) : 1593-1596.
8Bunout D, Garrido A, Suazo M, et al. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients [J ]. Nutrition, 2000, 16(2): 107-110.
9Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet, 1996,347 : 781-785.
10Fairfield KM , Fletcher RH . Vitamins for chronic disease prevention in adults-clinical applications. JAMA, 2002,287 : 3127-3129.
